Who
Fred Callori
Director
Company insider
Files Form 4 as: Director, LeonaBio; Director, Astria Therapeutics; Director, Landos Biopharma.
In numbers
- Trades disclosed
- 29
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 28 Jan 2021
- Last trade
- 23 Jun 2026
- Last filed
- 24 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jun 2026filed 24 Jun 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —2,333 at $0.00 | filing |
| 23 Jun 2026filed 24 Jun 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —2,333 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —56,000 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —56,000 at $0.00 | filing |
| 23 Jan 2026filed 23 Jan 2026 | Astria Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —14,166 | filing |
| 23 Jan 2026filed 23 Jan 2026 | Astria Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —8,333 | filing |
| 23 Jan 2026filed 23 Jan 2026 | Astria Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —14,100 | filing |
| 23 Jan 2026filed 23 Jan 2026 | Astria Therapeuticsoption or derivative | SEC FORM 4 Code D | —14,166 | filing |
| 23 Jan 2026filed 23 Jan 2026 | Astria Therapeuticsoption or derivative | SEC FORM 4 Code D | —8,333 | filing |
| 23 Jan 2026filed 23 Jan 2026 | Astria Therapeuticsoption or derivative | SEC FORM 4 Code D | —14,100 | filing |
| 23 Jan 2026filed 23 Jan 2026 | Astria Therapeuticsoption or derivative | SEC FORM 4 Code D | —14,100 | filing |
| 23 Jan 2026filed 23 Jan 2026 | Astria Therapeuticsoption or derivative | SEC FORM 4 Code D | —26,550 | filing |
| 23 Jan 2026filed 23 Jan 2026 | Astria Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —14,100 | filing |
| 23 Jan 2026filed 23 Jan 2026 | Astria Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —26,550 | filing |
| 11 Jun 2025filed 12 Jun 2025 | Astria Therapeuticsoption or derivative | SEC FORM 4 Code A | —26,550 at $0.00 | filing |
| 5 Jun 2024filed 6 Jun 2024 | Astria Therapeuticsoption or derivative | SEC FORM 4 Code A | —14,100 at $0.00 | filing |
| 23 May 2024filed 23 May 2024 | Landos Biopharmaoption or derivative | SEC FORM 4 Code D | —1,800 | filing |
| 23 May 2024filed 23 May 2024 | Landos Biopharmaoption or derivative | SEC FORM 4 Code D | —1,800 | filing |
| 23 May 2024filed 23 May 2024 | Landos Biopharmaoption or derivative | SEC FORM 4 Code D | —1,800 | filing |
| 2 Jun 2023filed 6 Jun 2023 | Astria Therapeuticsoption or derivative | SEC FORM 4 Code A | —14,100 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.